Literature DB >> 19040597

The determinants of granulocyte yield in 1198 granulocyte concentrates collected from unrelated volunteer donors mobilized with dexamethasone and granulocyte-colony-stimulating factor: a 13-year experience.

Karen Quillen1, Yu Ying Yau, Susan F Leitman.   

Abstract

BACKGROUND: The combination of granulocyte-colony-stimulating factor (G-CSF [filgrastim]) and dexamethasone (G-CSF/dex) is an effective granulocyte mobilization regimen, but the variables that affect donor neutrophil response and granulocyte collection yield are not well characterized. STUDY DESIGN AND METHODS: A computerized database containing records of 1198 granulocyte collections from 137 unrelated volunteer apheresis donors during a 13-year period was retrospectively analyzed. Donors were categorized by age, sex, and cumulative number of granulocyte donations. Complete blood counts at baseline and after G-CSF/dex stimulation were recorded. The outcome variables include the preprocedure absolute neutrophil count (preANC), which reflects G-CSF/dex stimulation, and the granulocyte product yield per liter processed (BagGranYield/L).
RESULTS: Higher baseline ANC and platelet (PLT) counts were significantly associated with higher preANC while a larger number of prior granulocytapheresis procedures was associated with lower preANC. Total filgrastim dose (used in weight-based dosing) did not significantly impact preANC or the granulocyte yield; weight-based dosing at 5 microg per kg and a uniform 480-microg dose produced equivalent preANC. PreANC and weight were the key determinants of granulocyte yield (BagGranYield/L).
CONCLUSION: Apheresis donors with higher baseline PLT counts and ANCs have higher ANCs after G-CSF/dex stimulation; donor age, weight, and sex do not have a significant impact. A uniform G-CSF dose of 480 microg is as effective as weight-based dosing at 5 microg per kg. Donor ANC monitoring should be considered after serial granulocytapheresis procedures.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19040597      PMCID: PMC3421027          DOI: 10.1111/j.1537-2995.2008.01997.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  14 in total

1.  Combined administration of G-CSF and dexamethasone for the mobilization of granulocytes in normal donors: optimization of dosing.

Authors:  W C Liles; E Rodger; D C Dale
Journal:  Transfusion       Date:  2000-06       Impact factor: 3.157

2.  Sustained decreases in platelet count associated with multiple, regular plateletpheresis donations.

Authors:  E F Lazarus; J Browning; J Norman; J Oblitas; S F Leitman
Journal:  Transfusion       Date:  2001-06       Impact factor: 3.157

3.  The use of stimulated granulocyte transfusions to prevent recurrence of past severe infections after allogeneic stem cell transplantation.

Authors:  J Paul Kerr; Effie Liakopolou; Jessica Brown; Jacqueline M Cornish; David Fleming; Edwin Massey; Anthony Oakhill; Derwood H Pamphilon; Stephen P Robinson; April Totem; Alexandra M P I Valencia; David I Marks
Journal:  Br J Haematol       Date:  2003-10       Impact factor: 6.998

4.  Neutrophil transfusions: kinetics and functions of neutrophils mobilized with granulocyte-colony-stimulating factor and dexamethasone.

Authors:  D C Dale; W C Liles; C Llewellyn; E Rodger; T H Price
Journal:  Transfusion       Date:  1998-08       Impact factor: 3.157

5.  Lineage-specific growth factors can compensate for stem and progenitor cell deficiencies at the postprogenitor cell level: an analysis of doubly TPO- and G-CSF receptor-deficient mice.

Authors:  Kenneth Kaushansky; Norma Fox; Nancy L Lin; W Conrad Liles
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

6.  A comparative trial of granulocyte-colony-stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal volunteers.

Authors:  W C Liles; J E Huang; C Llewellyn; D SenGupta; T H Price; D C Dale
Journal:  Transfusion       Date:  1997-02       Impact factor: 3.157

7.  Administration of G--CSF plus dexamethasone produces greater granulocyte concentrate yields while causing no more donor toxicity than G--CSF alone.

Authors:  D F Stroncek; Y Y Yau; J Oblitas; S F Leitman
Journal:  Transfusion       Date:  2001-08       Impact factor: 3.157

8.  Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections.

Authors:  Amar Safdar; Hend A Hanna; Maha Boktour; Dimitrios P Kontoyiannis; Ray Hachem; Benjamin Lichtiger; Emil J Freireich; Issam I Raad
Journal:  Cancer       Date:  2004-12-15       Impact factor: 6.860

9.  Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony-stimulating factor.

Authors:  C B Caspar; R A Seger; J Burger; J Gmür
Journal:  Blood       Date:  1993-06-01       Impact factor: 22.113

10.  Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population.

Authors:  Sumithira Vasu; Susan F Leitman; John F Tisdale; Matthew M Hsieh; Richard W Childs; A John Barrett; Daniel H Fowler; Michael R Bishop; Elizabeth M Kang; Harry L Malech; Cynthia E Dunbar; Hanh M Khuu; Robert Wesley; Yu Y Yau; Charles D Bolan
Journal:  Blood       Date:  2008-06-03       Impact factor: 22.113

View more
  4 in total

1.  Efficacy and side effects of granulocyte collection in healthy donors.

Authors:  Franziska Brockmann; Michael Kramer; Martin Bornhäuser; Gerhard Ehninger; Kristina Hölig
Journal:  Transfus Med Hemother       Date:  2013-07-19       Impact factor: 3.747

Review 2.  Role of granulocyte transfusions in invasive fusariosis: systematic review and single-center experience.

Authors:  Sameer S Kadri; Kenneth E Remy; Jeffrey R Strich; Juan Gea-Banacloche; Susan F Leitman
Journal:  Transfusion       Date:  2015-04-09       Impact factor: 3.157

3.  The effect of repeated stimulated granulocyte donations on hematopoietic indexes in donors: a 24-year donor center experience.

Authors:  James Szymanski; James Troendle; Susan Leitman; Hong Hong; Yu Ying Yau; Cathy Cantilena
Journal:  Transfusion       Date:  2018-11-16       Impact factor: 3.157

Review 4.  Granulocyte transfusions in children and adults with hematological malignancies: benefits and controversies.

Authors:  Chiara Cugno; Sara Deola; Perla Filippini; David F Stroncek; Sergio Rutella
Journal:  J Transl Med       Date:  2015-11-16       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.